Chapter 7 anti infective - antiviral for HIV/retroviruses + pneumocystis carinii agents (fungal based) Flashcards
Maraviroc (selzentry)
HIV + retrovirus
- blocks CCR5 rreceptors
- blocks CC5-tropic HIV (point of entry) from entering cell
indication
* cc5-tropic HIV, as part of combination therapy
effects
* rash, hepatotoxicity
contraindicated in renal impaired pt
talegravir (isentress)
dolutegravir (tivicay)
HIV + retrovirus
- blocks integrase
- it integrates viral DNA into the host genome
- which is needed for viral replication
indiction
* HIV
* part of combination therapy
effects
* dizziness
* serious skin reactions
Zidovudine (Retrovir)
lamivudine (epivir)
emtricitabine (emtriva)
abacavir (ziagen)
tenofvoir (Viread)
hiv + retrovirus
- nucleoside HIV reverse transcriptase inhibitor (HIV uses reverse transcriptase to convert its RNA into DNA (reverse transcription). )
indication
* HIV in cominbation therapy
* zidovudine – for prevention of maternal-fetal transmission of HIV
resistance
* mutations in reverse transcriptase
effects
* peripheral neuropathy
* pacnreatitis
* diarrhea
* insomnia
* n/v
* zidovudine-myelosuppression —> bone marrow suppression, is a decrease in bone marrow activity that results in reduced production of blood cells. Some blood cell disorders include: fewer red blood cells (anemia) fewer white blood cells (neutropenia)
pharmcokinetics:
* enhanced by renal or hepatic dysfunction
limited utility by itself
Doravirine (pifeltro)
nevirapine (Viramune)
delavirdine (recriptor)
efavirenz (sustiva)
etravirine (intelence)
rilpivirine (edurant)
hiv + retrovirus
non-nucleoside inihbitor of HIV rever transcriptase
indication
* HIV
* never as monotherapy — rapid development to resistance
ritonavir (norvifr)
indinavir (crixivan)
squinavir (invirase)
nelfinavir (virecept)
fosamprenavir (lexiva)
atazanavir (reyataz)
tipranavir (aptivus)
darunavir (prezista)
hiv + retro
- protease inhibitor
- enzhyme necessary for cleaving the gal-pol precurser
- results in immature virus formation
indication
* HIV in combination
resistance
* mutations in protease sequence
effects
* neurologic sx (weakness, anorexia, parasthesias)
* Indinavir —- inc risk of kidney stones
Potentially serious drug interactions d/t p450 enzyme competition
enfuvirtide (fuzeon)
hiv + retro
- fusion inhibitors
- block HIV from entering CD4 T- cells
use
HIV w/ combination therapy
ibalizumab (trogarzo)
- post attachment inhibitors (block cd4 receptors on the surface of T-cells; HIV needs the cd4 receptor cell entry
use:
* HIV in combination therapy
combination HIV drugs
- 2 dozen combination therapies
trimethoprim-sulfamethoxazole (bactrim, septra)
pneumocystis carinii agents
- inhibits folate synthesis pathway
indication:
* drug of choice for PCP prphylaxis in immuno-suppressed (oral)
* IV —- for PCP infection
* Pneumocystis pneumonia (PCP) is a serious infection caused by the fungus Pneumocystis jirovecii. Most people who get PCP have a medical condition that weakens their immune system, like HIV/AIDS, or take medicines (such as corticosteroids) that lower the body’s ability to fight germs and sickness.
pentamidine (pentam)
penumocystis carinii agent
- unknown mech
indication
* nebulized form — alternative PCP prophylaxis
* IV – alternative PCP tx
effect
* bronchoconstriction frequent – use w/ bronchodilator
dapsone
pneumocystis carinii agent
- unknown mech
indication
* alternative for PCP prophylaxis
atovaquone (mepron)
pneumocystis carinii agent
- unknown mech
indication
* tx for mild PCP in TMP-SMZ resistant patient
* Trimethoprim / Sulfamethoxazole (TMP SMZ)